Some were concerned about increased imaging and interpretation times associated with DBT.
Adopting digital breast tomosynthesis (DBT) is not associated with a decrease in screening mammography capacity, according to a study published in the American Journal of Roentgenology.
Researchers from several states sought to determine whether adoption of DBT was associated with a decrease in screening mammography capacity across Breast Cancer Screening Consortium facilities, given concerns about increasing imaging and interpretation times associated with DBT.
The researchers collected facility characteristics and examination volume data from Breast Cancer Screening Consortium facilities that adopted DBT between 2011 and 2014. They evaluated differences between monthly screening volumes during the 12-month preadoption period and the 12-month postadoption period (with the two periods separated by a 3-month lag) and tested for changes in month-to-month facility-level screening volume during the preadoption and postadoption periods.
Related article: DBT Better Detects Cancer in Dense Breasts
The results showed that across five regional breast imaging registries, 15 of 83 facilities (18.1%) adopted DBT for screening between 2011 and 2014.
Facility-level monthly screening volumes were slightly higher during the postadoption versus preadoption periods. Monthly screening volumes remained relatively stable within the preadoption period and the postadoption period.
The researchers concluded that in a cohort of facilities with varied characteristics, monthly screening examination volumes did not decrease after DBT adoption.
Stay at the forefront of radiology with the Diagnostic Imaging newsletter, delivering the latest news, clinical insights, and imaging advancements for today’s radiologists.
Mammography Study: AI Facilitates Greater Accuracy and Longer Fixation Time on Suspicious Areas
July 8th 2025While noting no differences in sensitivity, specificity or reading time with adjunctive AI for mammography screening, the authors of a new study noted a 4 percent higher AUC and increased fixation time on lesion regions.
Can Contrast-Enhanced Mammography be a Viable Screening Alternative to Breast MRI?
June 17th 2025While the addition of contrast-enhanced mammography (CEM) to digital breast tomosynthesis (DBT) led to over a 13 percent increase in false positive cases, researchers also noted over double the cancer yield per 1,000 women in comparison to DBT alone.
Contrast-Enhanced Mammography and High-Concentration ICM Dosing: What a New Study Reveals
June 16th 2025New research showed a 96 to 97 percent sensitivity for contrast-enhanced mammography (CEM) with an increased iodine delivery rate facilitating robust contrast enhancement for women with aggressive breast cancer.